Tympanic membrane perforation
ICD-10 H72ICD-11 AB13

Treatment of Tympanic Membrane Perforation with Sensorineural Hearing Loss

Clinical scenario

This protocol addresses patients presenting with tympanic membrane perforation who also have concurrent sensorineural hearing loss (SNHL). The coexistence of these two conditions defines a specific clinical sub-population requiring targeted management distinct from uncomplicated perforation alone.

Condition

Sensorineural hearing loss with tympanic membrane perforation — a scenario in which inner-ear or auditory-nerve pathology accompanies the structural disruption of the tympanic membrane, raising distinct therapeutic priorities.

Treatment approach (partial)

Management in this setting involves an oral corticosteroid-based regimen structured as a high-dose weaning course, aligned with established SSNHL clinical practice guidance.

Full dosing schedule, duration, and protocol algorithm available via the link below →
Instant Access to Structured Evidence-Based Regimens

References

For SNHL with TMP treat with high dose weaning regimen oral prednisolone as per SSNHL Clinical Practice Guideline.


View source ↗